Richard Scranton
2018
In 2018, Richard Scranton earned a total compensation of $2.3M as Chief Medical Officer at Pacira Pharmaceuticals, a 34% increase compared to previous year.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Option Awards | $1,230,807 |
| Salary | $457,692 |
| Stock Awards | $302,006 |
| Other | $26,045 |
| Total | $2,266,550 |
Scranton received $1.2M in option awards, accounting for 54% of the total pay in 2018.
Scranton also received $250K in bonus, $457.7K in salary, $302K in stock awards and $26K in other compensation.
Rankings
In 2018, Richard Scranton's compensation ranked 5,087th out of 14,244 executives tracked by ExecPay. In other words, Scranton earned more than 64.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,087 out of 14,244 | 64th |
Division Manufacturing | 1,914 out of 5,759 | 67th |
Major group Chemicals And Allied Products | 703 out of 2,122 | 67th |
Industry group Drugs | 587 out of 1,811 | 68th |
Industry Pharmaceutical Preparations | 452 out of 1,385 | 67th |
Pay ratio
| Richard Scranton's Pay | $2,266,550 |
|---|---|
| Median Employee's Pay | $177,153 |
| Pay Ratio | 13to 1 |
In 2018, the annual total compensation of Richard Scranton was $2,266,550.
The annual total compensation of the median employee at Pacira Pharmaceuticals was $177,153.
The ratio of Richard Scranton's pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on April 22, 2019.
Scranton's colleagues
We found four more compensation records of executives who worked with Richard Scranton at Pacira Pharmaceuticals in 2018.